Nisa Investment Advisors
ABOS icon

Nisa Investment Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History

Nisa Investment Advisors’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28K Hold
1,229
– – ﹤0.01% 2679
2026
Q1 		$2.9K Hold
1,229
– – ﹤0.01% 2558
2025
Q4 		$2.59K Hold
1,229
– – ﹤0.01% 2574
2025
Q3 		$2.1K Hold
1,229
– – ﹤0.01% 2608
2025
Q2 		$1.43K Buy
+1,229
New +$1.32K ﹤0.01% 2675
2025
Q1 		– Sell
-356
Closed -$612 – 2983
2024
Q4 		$612 Buy
356
+256
+256% +$616 ﹤0.01% 2788
2024
Q3 		$248 Buy
+100
New +$271 ﹤0.01% 2824

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Nisa Investment Advisors's ABOS Position: Q2 2026 in Review

Nisa Investment Advisors held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 1,229 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2679.

Nisa Investment Advisors first reported a position in ABOS in Q3 2024 and has held it in 7 quarters since. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Nisa Investment Advisors held 1,229 shares of Acumen Pharmaceuticals worth $3.28K as of Q2 2026.
  • Nisa Investment Advisors left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2679 holding.
  • Nisa Investment Advisors first reported a position in Acumen Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.